The evidence-based pharmacotherapy of social anxiety disorder
about
Treating comorbid anxiety and depression: Psychosocial and pharmacological approachesBridging the gap between education and appropriate use of benzodiazepines in psychiatric clinical practiceBehavioral inhibition in rhesus monkeys (Macaca mulatta) is related to the airways response, but not immune measures, commonly associated with asthmaBrain oxytocin in social fear conditioning and its extinction: involvement of the lateral septumA preliminary study of individual cognitive behavior therapy for social anxiety disorder in Japanese clinical settings: a single-arm, uncontrolled trialDifferentiating the subtypes of social anxiety disorder.Neurobiological correlates of social anxiety disorder: an update.Pregabalin for the treatment of social anxiety disorder.Generalized social anxiety disorder: A still-neglected anxiety disorder 3 decades since Liebowitz's review.Serotonin and brain function: a tale of two receptorsOxytocin and Anxiety Disorders: Translational and Therapeutic Aspects.Diazepam actions in the VTA enhance social dominance and mitochondrial function in the nucleus accumbens by activation of dopamine D1 receptors.Long-Term Pharmacological Treatments of Anxiety Disorders: An Updated Systematic Review.Recent Insight Into the Subtypes of Social Anxiety Disorder.Pharmacotherapy for social anxiety disorder (SAnD).The Place of Antipsychotics in the Therapy of Anxiety Disorders and Obsessive-Compulsive Disorders.Serotonin synthesis rate and the tryptophan hydroxylase-2: G-703T polymorphism in social anxiety disorder.Evidence-based pharmacological treatment of anxiety disorders, post-traumatic stress disorder and obsessive-compulsive disorder: a revision of the 2005 guidelines from the British Association for Psychopharmacology.
P2860
Q26770334-657870F1-CA33-4ABF-9ED5-6D736C3677CCQ26800235-3303D850-075B-42C0-9927-0252C97B760EQ27309219-9C4AAD46-21BC-4109-AFB4-FC834A331F5EQ34499315-391425C7-5EB7-4AF5-AB16-1C4738CD6699Q36698280-D481EB82-2290-4F65-9B79-B87A195C8D93Q38157037-DBBC8D97-42E5-4A4C-A492-8AD0AE26ED31Q38191310-429A3C63-8C1E-4260-8D8F-8CFF62433102Q38264189-15FE7AE1-308F-40D7-A2B3-72AE0599B45EQ38539809-BDAFF870-4DC7-41B5-91A0-2D643A052CA2Q38600048-A4DAE26A-B3F1-4D1B-8664-DC35C4AA9CDFQ38624604-F3BD7D2E-028C-415C-A9B9-4B5C23466BAAQ38670092-2C02CB0D-6C10-44DA-87DA-9DBAB32B4858Q38718213-4E5D5705-41E9-4355-88F4-A07352D4485BQ38790288-679784B8-E29B-45D2-AB19-8E14AFBCD2F7Q47593921-B10011F8-30E3-484F-8DB6-C1B73058BC76Q47624983-E5D0363D-F21E-4A39-A8E1-CECA01E25D57Q48729099-9D7659AE-9F13-47DA-A711-A62D18F482EDQ53091817-09592BC2-16D8-43C8-B369-AD8E016A67E6
P2860
The evidence-based pharmacotherapy of social anxiety disorder
description
2013 nî lūn-bûn
@nan
2013 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
The evidence-based pharmacotherapy of social anxiety disorder
@ast
The evidence-based pharmacotherapy of social anxiety disorder
@en
The evidence-based pharmacotherapy of social anxiety disorder
@nl
type
label
The evidence-based pharmacotherapy of social anxiety disorder
@ast
The evidence-based pharmacotherapy of social anxiety disorder
@en
The evidence-based pharmacotherapy of social anxiety disorder
@nl
prefLabel
The evidence-based pharmacotherapy of social anxiety disorder
@ast
The evidence-based pharmacotherapy of social anxiety disorder
@en
The evidence-based pharmacotherapy of social anxiety disorder
@nl
P2093
P2860
P1476
The evidence-based pharmacotherapy of social anxiety disorder
@en
P2093
Franklin R Schneier
Laura B Bragdon
Michael R Liebowitz
P2860
P304
P356
10.1017/S1461145712000119
P407
P577
2013-02-01T00:00:00Z